Showing results (91-100 of 232) with videos related to
Sort By:
Pageof 24
Cytoskeleton (Hoboken, N.J.)|August 13, 2015
Myosin VI and cardiomyopathy: Left ventricular hypertrophy, fibrosis, and both cardiac and pulmonary vascular endothelial cell defects in the Snell's waltzer mousePeter S Hegan, Anthony A Lanahan, Michael Simons, et al.EMBO Molecular Medicine|May 19, 2016
Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progressionPei-Yu Chen, Lingfeng Qin, Guangxin Li, et al.Molecular Cell|October 15, 2008
Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cellsChohreh Partovian, Rong Ju, Zhen W Zhuang, et al.Current Pharmaceutical Design|June 8, 2002
Medical imaging techniques in the evaluation of strategies for therapeutic angiogenesisJustin D Pearlman, Roger J Laham, Mark Post, et al.Vascular Medicine (London, England)|January 29, 2005
Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trialRichard J Powell, John Dormandy, Michael Simons, et al.Biochemistry|July 23, 2003
Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activityMaria Gaczynska, Pawel A Osmulski, Youhe Gao, et al.Developmental Biology|November 1, 2019
FRS2α-dependent cell fate transition during endocardial cushion morphogenesisDongying Chen, Xiaolong Zhu, Natalie Kofler, et al.Plos One|March 8, 2014
Inter-cellular exchange of cellular components via VE-cadherin-dependent trans-endocytosisTakashi Sakurai, Melissa J Woolls, Suk-Won Jin, et al.The Journal of Biological Chemistry|September 5, 2006
The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functionsMary Drinane, Jannine Walsh, Jessica Mollmark, et al.Journal of Molecular Biology|October 1, 2008
Molecular basis for proline- and arginine-rich peptide inhibition of proteasomeAsokan Anbanandam, Diana C Albarado, Daniela C Tirziu, et al.Pageof 24